新一代优化(TANGO)治疗方案的抗vegf治疗新血管性年龄相关性黄斑变性:理论基础,设计和模拟研究

Clinical ophthalmology (Auckland, N.Z.) Pub Date : 2025-04-29 eCollection Date: 2025-01-01 DOI:10.2147/OPTH.S518756
Yousif Subhi, Lena Michelle Mørup Andersen, Javad Nouri Hajari, Naayaab Henningsen, Karin Ingemann Larsen, Miklos Schneider
{"title":"新一代优化(TANGO)治疗方案的抗vegf治疗新血管性年龄相关性黄斑变性:理论基础,设计和模拟研究","authors":"Yousif Subhi, Lena Michelle Mørup Andersen, Javad Nouri Hajari, Naayaab Henningsen, Karin Ingemann Larsen, Miklos Schneider","doi":"10.2147/OPTH.S518756","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To present the rationale and design of the Tailored Anti-VEGF therapy with New Generation Optimizations (TANGO) treatment regimen for neovascular age-related macular degeneration and to simulate potential number of visits and injections with TANGO and compare to other treatment regimens.</p><p><strong>Methods: </strong>This is a descriptive short report of the rationale and design of TANGO. The purpose of TANGO is to lessen the burden of therapy with new generation anti-VEGF medications that have better durability. We also simulate the potential number of visits and injections during the first year with TANGO and compare these numbers to other treatment regimens.</p><p><strong>Results: </strong>Our report describes TANGO and provides a flow chart for its use. Our simulations suggest that TANGO may lead to a reduced number of visits and injections.</p><p><strong>Conclusion: </strong>Our simulations suggest that employing TANGO may lead to a reduced number of visits and anti-VEGF injections while still providing intensive therapy for those who require it. However, it should be emphasized that this is a descriptive report and a simulation study, and clinical real-world studies of efficacy and safety using TANGO are warranted to better understand implications of employing TANGO in routine clinical practice.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"1435-1441"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12049126/pdf/","citationCount":"0","resultStr":"{\"title\":\"Tailored Anti-VEGF Therapy with New Generation Optimizations (TANGO) Treatment Regimen for Neovascular Age-Related Macular Degeneration: Rationale, Design, and Simulation Study.\",\"authors\":\"Yousif Subhi, Lena Michelle Mørup Andersen, Javad Nouri Hajari, Naayaab Henningsen, Karin Ingemann Larsen, Miklos Schneider\",\"doi\":\"10.2147/OPTH.S518756\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To present the rationale and design of the Tailored Anti-VEGF therapy with New Generation Optimizations (TANGO) treatment regimen for neovascular age-related macular degeneration and to simulate potential number of visits and injections with TANGO and compare to other treatment regimens.</p><p><strong>Methods: </strong>This is a descriptive short report of the rationale and design of TANGO. The purpose of TANGO is to lessen the burden of therapy with new generation anti-VEGF medications that have better durability. We also simulate the potential number of visits and injections during the first year with TANGO and compare these numbers to other treatment regimens.</p><p><strong>Results: </strong>Our report describes TANGO and provides a flow chart for its use. Our simulations suggest that TANGO may lead to a reduced number of visits and injections.</p><p><strong>Conclusion: </strong>Our simulations suggest that employing TANGO may lead to a reduced number of visits and anti-VEGF injections while still providing intensive therapy for those who require it. However, it should be emphasized that this is a descriptive report and a simulation study, and clinical real-world studies of efficacy and safety using TANGO are warranted to better understand implications of employing TANGO in routine clinical practice.</p>\",\"PeriodicalId\":93945,\"journal\":{\"name\":\"Clinical ophthalmology (Auckland, N.Z.)\",\"volume\":\"19 \",\"pages\":\"1435-1441\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12049126/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical ophthalmology (Auckland, N.Z.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/OPTH.S518756\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical ophthalmology (Auckland, N.Z.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OPTH.S518756","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:介绍新一代优化(TANGO)治疗方案治疗新生血管性年龄相关性黄斑变性的基本原理和设计,模拟TANGO的潜在就诊次数和注射次数,并与其他治疗方案进行比较。方法:这是一个描述性的简短报告的基本原理和设计的TANGO。TANGO的目的是减轻新一代抗vegf药物治疗的负担,这些药物具有更好的持久性。我们还模拟了TANGO第一年的潜在就诊和注射次数,并将这些数字与其他治疗方案进行比较。结果:我们的报告描述了TANGO,并提供了其使用流程图。我们的模拟表明TANGO可能会减少就诊和注射的次数。结论:我们的模拟表明,使用TANGO可能会减少就诊次数和抗vegf注射,同时仍然为那些需要它的人提供强化治疗。然而,应该强调的是,这是一份描述性报告和一项模拟研究,为了更好地理解在常规临床实践中使用TANGO的含义,有必要对TANGO的有效性和安全性进行临床真实世界的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Tailored Anti-VEGF Therapy with New Generation Optimizations (TANGO) Treatment Regimen for Neovascular Age-Related Macular Degeneration: Rationale, Design, and Simulation Study.

Purpose: To present the rationale and design of the Tailored Anti-VEGF therapy with New Generation Optimizations (TANGO) treatment regimen for neovascular age-related macular degeneration and to simulate potential number of visits and injections with TANGO and compare to other treatment regimens.

Methods: This is a descriptive short report of the rationale and design of TANGO. The purpose of TANGO is to lessen the burden of therapy with new generation anti-VEGF medications that have better durability. We also simulate the potential number of visits and injections during the first year with TANGO and compare these numbers to other treatment regimens.

Results: Our report describes TANGO and provides a flow chart for its use. Our simulations suggest that TANGO may lead to a reduced number of visits and injections.

Conclusion: Our simulations suggest that employing TANGO may lead to a reduced number of visits and anti-VEGF injections while still providing intensive therapy for those who require it. However, it should be emphasized that this is a descriptive report and a simulation study, and clinical real-world studies of efficacy and safety using TANGO are warranted to better understand implications of employing TANGO in routine clinical practice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信